No Data
No Data
Kangwei Century (688426.SH): First repurchase of 59,000 shares
Gelonghui, March 4, 丨 Kang Wei Century (688426.SH) announced that on March 4, 2024, Jiangsu Kangwei Century Biotechnology Co., Ltd. repurchased 59,262 shares of the company's shares for the first time through centralized bidding transactions, accounting for 0.0528% of the company's total share capital of 112,227,568 shares. The highest price for the repurchase transaction was 21.64 yuan/share, and the lowest price was 20.98 yuan/share. The total amount of capital paid was RMB 1,274,479.33.
Kangwei Century (688426): Molecular testing industry chain layout Helicobacter pylori stool test creates a second growth curve
Key investment points Investment logic: The traditional molecular testing business covers the entire “core materials+kit+testing service” business process, bringing steady growth; Helicobacter pylori drug resistance testing products are expected to be approved in 2024, bringing a second growth curve.
Kangwei Century (688426.SH): net loss of 81.013,600 yuan in 2023
Gelonghui, Feb. 27丨Kang Wei Century (688426.SH) announced the 2023 Annual Results Report. During the reporting period, the company achieved operating income of 177.455,800 yuan, a year-on-year decrease of 65.98%; realized total profit of -86.773,900 yuan, a year-on-year decrease of 144.41%; realized net profit attributable to owners of the parent company - 81.013,600 yuan, a year-on-year decrease of 150.87%; realized net profit attributable to owners of the parent company - 116.5982 million yuan, a year-on-year decrease of 116.5982 million yuan, a year-on-year decrease of 116.5982 million yuan. 178.31%
Express News | Kangwei Century: Plans to buy back the company's shares for 30 million yuan to 60 million yuan
Jiangsu CoWin Biotech Co., Ltd.'s (SHSE:688426) 37% Share Price Plunge Could Signal Some Risk
The Jiangsu CoWin Biotech Co., Ltd. (SHSE:688426) share price has fared very poorly over the last month, falling by a substantial 37%. For any long-term shareholders, the last month ends a year to
Kang Wei (688426.SH) issued a forecast loss. The net loss is expected to be 75 million yuan to 90 million yuan in 2023, changing from profit to loss over the same period last year
According to Zhitong Finance App News, Kang Wei Century (688426.SH) announced that the company expects to achieve a loss in 2023 net profit attributable to the owner of the parent company compared with the same period last year. The net profit attributable to the owner of the parent company is a loss of 75 million yuan to 90 million yuan, a decrease of 147.09% to 156.51% compared with the same period last year. Net profit attributable to owners of the parent company in 2022:15.9258,900 yuan. During the reporting period, it was affected by factors such as domestic and foreign macroeconomic environments, changes in health prevention and control policies, and changes in market demand in the molecular testing industry
No Data